Selectica Inc. (NASDAQ:DTRM) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Monday.

According to Zacks, “Determine, Inc. offers contract management, supply management and configuration solutions. The Company offers SmartContracts, SmartSource and SmartAnalytics. SmartContracts, a solution that streamlines contract processes from request, authoring, negotiation, approval and e-signature through ongoing obligations management, analysis, reporting and renewals; SmartSource, an enterprise scale solution to support the processes of supplier on-boarding, supplier selection and on-going supplier management; Selectica Configuration Solution, which enables enterprise organizations to create valid product and service combinations. It operates primarily in the United States, Canada, India, New Zealand, Switzerland, Germany, Hong Kong, Ireland, Norway and the United Kingdom. Determine, Inc., formerly known as Selectica, Inc., is headquartered in San Mateo, California. “

Separately, Needham & Company LLC reaffirmed a “buy” rating and issued a $7.00 price target on shares of Selectica in a report on Friday, June 17th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. Selectica currently has an average rating of “Hold” and an average target price of $4.58.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Shares of Selectica (NASDAQ:DTRM) traded down 0.52% on Monday, hitting $1.93. The stock had a trading volume of 16,248 shares. The firm has a 50-day moving average of $1.78 and a 200 day moving average of $1.60. Selectica has a 1-year low of $0.82 and a 1-year high of $5.79. The company’s market capitalization is $22.02 million.

Selectica (NASDAQ:DTRM) last posted its quarterly earnings results on Wednesday, August 10th. The company reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.02. The company had revenue of $6.50 million for the quarter, compared to analysts’ expectations of $6.75 million. Selectica had a negative net margin of 50.63% and a negative return on equity of 67.81%. The company’s revenue for the quarter was up 3.2% compared to the same quarter last year. On average, equities analysts anticipate that Selectica will post ($0.34) earnings per share for the current fiscal year.

In other news, major shareholder Lloyd I. Miller III purchased 18,746 shares of Selectica stock in a transaction dated Thursday, July 21st. The stock was purchased at an average cost of $1.74 per share, for a total transaction of $32,618.04. Following the transaction, the insider now directly owns 30,780 shares of the company’s stock, valued at $53,557.20. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. Also, major shareholder Lloyd I. Miller III purchased 25,000 shares of Selectica stock in a transaction dated Wednesday, July 20th. The shares were purchased at an average price of $1.74 per share, with a total value of $43,500.00. Following the completion of the transaction, the insider now directly owns 30,780 shares in the company, valued at $53,557.20. The disclosure for this purchase can be found here. 6.97% of the stock is currently owned by corporate insiders.

Selectica Company Profile

Determine, Inc, (Determine), formerly Selectica, Inc, is a provider of enterprise contract management, supply management and configuration solutions. The Company is engaged in providing software as a service (SaaS) Source to Pay and Enterprise Contract Lifecyclem Management (ECLM) solutions. Its Source to Pay software suite includes strategic sourcing, supplier management, contract management and procure-to-pay applications.

5 Day Chart for NASDAQ:DTRM

Get a free copy of the Zacks research report on Selectica (DTRM)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Selectica Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Selectica Inc. and related companies with's FREE daily email newsletter.